Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Abraxis_BioScience> ?p ?o }
Showing triples 1 to 44 of
44
with 100 triples per page.
- Abraxis_BioScience abstract "Abraxis BioScience is a global biopharmaceutical company dedicated to meeting the needs of critically ill patients, with over 2000 employees worldwide. Abraxis' portfolio includes the world's first protein-based nanoparticle chemotherapeutic compound called nab Technology. From this the company has developed Abraxane, a treatment for metastatic breast cancer. On June 30, 2010, it was announced that Abraxis BioScience would be acquired by Celgene Corporation.".
- Abraxis_BioScience wikiPageExternalLink www.abraxisbio.com.
- Abraxis_BioScience wikiPageExternalLink www.abraxisbio.com.
- Abraxis_BioScience wikiPageID "25034844".
- Abraxis_BioScience wikiPageLength "2623".
- Abraxis_BioScience wikiPageOutDegree "9".
- Abraxis_BioScience wikiPageRevisionID "674970629".
- Abraxis_BioScience wikiPageWikiLink Abraxane.
- Abraxis_BioScience wikiPageWikiLink Biopharmaceutical.
- Abraxis_BioScience wikiPageWikiLink Breast_cancer.
- Abraxis_BioScience wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- Abraxis_BioScience wikiPageWikiLink Celgene.
- Abraxis_BioScience wikiPageWikiLink Celgene_Corporation.
- Abraxis_BioScience wikiPageWikiLink Chemotherapy.
- Abraxis_BioScience wikiPageWikiLink Critical_illness.
- Abraxis_BioScience wikiPageWikiLink Intensive_care_medicine.
- Abraxis_BioScience wikiPageWikiLink Metastasis.
- Abraxis_BioScience wikiPageWikiLink Nanoparticle.
- Abraxis_BioScience wikiPageWikiLink Protein-bound_paclitaxel.
- Abraxis_BioScience wikiPageWikiLinkText "Abraxis BioScience".
- Abraxis_BioScience wikiPageWikiLinkText "Abraxis BioScience#Restructure of 2007".
- Abraxis_BioScience hasPhotoCollection Abraxis_BioScience.
- Abraxis_BioScience wikiPageUsesTemplate Template:Med-company-stub.
- Abraxis_BioScience wikiPageUsesTemplate Template:NASDAQ.
- Abraxis_BioScience wikiPageUsesTemplate Template:Reflist.
- Abraxis_BioScience subject Category:Biotechnology_companies_of_the_United_States.
- Abraxis_BioScience hypernym Company.
- Abraxis_BioScience type Agent.
- Abraxis_BioScience type Company.
- Abraxis_BioScience type Company.
- Abraxis_BioScience type Person.
- Abraxis_BioScience type Agent.
- Abraxis_BioScience type NaturalPerson.
- Abraxis_BioScience type Thing.
- Abraxis_BioScience type Q215627.
- Abraxis_BioScience type Q5.
- Abraxis_BioScience type Person.
- Abraxis_BioScience comment "Abraxis BioScience is a global biopharmaceutical company dedicated to meeting the needs of critically ill patients, with over 2000 employees worldwide. Abraxis' portfolio includes the world's first protein-based nanoparticle chemotherapeutic compound called nab Technology. From this the company has developed Abraxane, a treatment for metastatic breast cancer. On June 30, 2010, it was announced that Abraxis BioScience would be acquired by Celgene Corporation.".
- Abraxis_BioScience label "Abraxis BioScience".
- Abraxis_BioScience sameAs m.03p1cn2.
- Abraxis_BioScience sameAs Q4669505.
- Abraxis_BioScience sameAs Q4669505.
- Abraxis_BioScience wasDerivedFrom Abraxis_BioScience?oldid=674970629.
- Abraxis_BioScience isPrimaryTopicOf Abraxis_BioScience.